Accelerant (ARX) vs Ryan Specialty (RYAN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Accelerant (ARX) has outperformed Ryan Specialty (RYAN) over the past year, gaining 37.4% versus a loss of 35.4%. Ryan Specialty is the larger company by market cap ($9.64 billion vs $4.29 billion), about 2.2 times the size, while Accelerant is growing revenue faster (+51.5% vs +21.3%). On valuation, Ryan Specialty trades at a lower forward P/E (15.5x vs 21.0x for Accelerant).
Ryan Specialty pays a dividend yielding 1.33%, while Accelerant does not currently pay one. Ryan Specialty converts more of its revenue into profit, with a net margin of 2.1% versus -147.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARX | RYAN |
|---|---|---|
| Share price | $19.75 | $37.60 |
| Market cap | $4.29B | $9.64B |
| 1-day change | +0.10% | -1.83% |
| YTD return | +20.80% | -27.17% |
| 1-year return | +37.44% | -35.41% |
| 5-year return | — | +1.13% |
| P/E ratio (TTM) | — | 52.96 |
| Forward P/E | 21.04 | 15.47 |
| EPS (TTM) | $-6.22 | $0.71 |
| Dividend yield | 0.00% | 1.33% |
| Annual dividend | $0.00 | $0.50 |
| Revenue (latest FY) | $912.90M | $3.05B |
| Revenue growth (YoY) | +51.49% | +21.28% |
| Net income (latest FY) | $-1.35B | $63.40M |
| Operating margin | — | 16.18% |
| Net margin | -147.35% | 2.08% |
| 52-week high | $19.90 | $58.94 |
| 52-week low | $9.18 | $29.28 |
| Distance from 52-week high | -0.75% | -36.21% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +2.53% | +33.22% |
| Average volume | 3.65M | 1.94M |
| Shares outstanding | 118.55M | 122.08M |
| Employees | 862 | 6,171 |
| Sector | Finance | Finance |
| Industry | Specialty Insurers | Specialty Insurers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Ryan Specialty is about 2.2 times larger than Accelerant by market value ($9.64B vs $4.29B).
- ARX has outperformed RYAN by 72.8 percentage points over the past year.
- Ryan Specialty offers a meaningfully higher dividend yield (1.33% vs 0.00%).
- Ryan Specialty is more profitable, keeping 2.1 cents of every revenue dollar as net income versus -147.4 cents for Accelerant.
- Accelerant grew revenue faster in its latest fiscal year (+51.49% vs +21.28%).
About Accelerant
ARX stock →Accelerant Holdings, together with its subsidiaries, operates a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners. It operates through Exchange Services, MGA Operations, and Underwriting segments.
Finance · Specialty Insurers · 862 employees
About Ryan Specialty
RYAN stock →Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, Singapore, and internationally.
Finance · Specialty Insurers · 6,171 employees
ARX vs RYAN FAQ
Which is bigger, Accelerant or Ryan Specialty?
Ryan Specialty (RYAN) is larger, with a market capitalization of $9.64B compared with $4.29B for Accelerant (ARX).
Which stock has performed better over the past year, ARX or RYAN?
ARX returned +37.44% over the past 12 months, compared with -35.41% for RYAN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Accelerant or Ryan Specialty?
Ryan Specialty pays a dividend yielding 1.33%, while Accelerant does not currently pay a regular dividend.
Are Accelerant and Ryan Specialty in the same industry?
Yes. Both are classified in the Specialty Insurers industry within the Finance sector.